1mig: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Theoretical_model}} | {{Theoretical_model}} | ||
[[Image:1mig.png|left|200px]] | [[Image:1mig.png|left|200px]] | ||
{{STRUCTURE_1mig| PDB=1mig | SCENE= }} | {{STRUCTURE_1mig| PDB=1mig | SCENE= }} | ||
===CATALYTIC ANTIBODY MODEL AND MUTAGENESIS IMPLICATE ARGININE IN TRANSITION-STATE STABILIZATION=== | ===CATALYTIC ANTIBODY MODEL AND MUTAGENESIS IMPLICATE ARGININE IN TRANSITION-STATE STABILIZATION=== | ||
{{ABSTRACT_PUBMED_8289310}} | {{ABSTRACT_PUBMED_8289310}} | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:008289310</ref><references group="xtra"/> | ||
[[Category: Getzoff, E D]] | [[Category: Getzoff, E D]] | ||
[[Category: Roberts, V A]] | [[Category: Roberts, V A]] | ||
Revision as of 09:14, 21 October 2012
CATALYTIC ANTIBODY MODEL AND MUTAGENESIS IMPLICATE ARGININE IN TRANSITION-STATE STABILIZATION
Template:ABSTRACT PUBMED 8289310
Reference
- Roberts VA, Stewart J, Benkovic SJ, Getzoff ED. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization. J Mol Biol. 1994 Jan 21;235(3):1098-116. PMID:8289310 doi:https://dx.doi.org/10.1006/jmbi.1994.1060
